Valentina Rucker

Valentina Rucker

Wilson Sonsini Goodrich & Rosati

Contact  |  View Bio  |  RSS

Latest Publications

Share:

Spotlight on Antitrust: Asia Edition

In this issue: - The U.S. DOJ Secures Two Extraditions of Foreign Nationals on Antitrust Charges: Who Is Next? - U.S. Circuit Courts Limit Reach of Sherman Act Against Asian Cartel - Mark Rosman, Partner...more

6/17/2014 - Antitrust Conspiracies Antitrust Litigation Cartels DOJ Enforcement Actions Extradition Foreign Nationals Sherman Act

Notifications and Names: FTC Workshop Explores Effect of State Legislation and Naming Conventions on Follow-On Biologic...

Biologic medicines represent some of the most significant—both clinically and financially— pharmaceutical products in the United States today. Biologics have had remarkable success in the treatment of patients with many...more

3/21/2014 - Biologics FTC Pharmaceutical Prescription Drugs

FTC Workshop to Revisit Competition Issues Regarding Follow-On Biologics

Five years ago, the Federal Trade Commission (FTC) waded into the debate regarding the benefits and potential competition issues posed by the introduction of "follow-on biologics." Now, some three years after Congress...more

11/21/2013 - Biologics BPCIA Competition FDA FTC Hatch-Waxman Pharmaceutical Prescription Drugs

"Eye on Privacy" Newsletter - September 2013

In this issue: - Digital Advertising Alliance Releases Guidance on the Application of Its Self-Regulatory Principles to the Mobile Environment - TCPA Update: Recent Decisions and Significant Upcoming Change to...more

9/24/2013 - CalOPPA Data Brokers FCRA FTC Mobile Apps Mobile Devices Privacy Laws Privacy Policy Proposed Legislation Social Media Social Media Policy TCPA

FTC v. Actavis: "Reverse Payments"—Not Presumptively Lawful, Not Presumptively Unlawful, But Subject to a Rule-of-Reason Analysis

On June 17, 2013, after years of litigation in the lower courts, the United States Supreme Court issued its long-awaited decision in FTC v. Actavis. The 5-3 decision, however, did not have a clear winner, and the case was...more

6/19/2013 - Actavis Inc. FTC FTC v Actavis Generic Drugs Pay-For-Delay Pharmaceutical Prescription Drugs Reverse Payment Settlement Agreements SCOTUS

5 Results
|
View per page
Page: of 1